Asia
Philippines Begins Avigan Clinical Trials for COVID-19 Treatment
Supplied photo shows tablets of the anti-influenza drug Avigan. / Fujifilm / Kyodo
By Kyodo News 5 August 2020
MANILA—The Philippine government said Tuesday that it has begun clinical trials for Japanese anti-flu drug Avigan to see whether it would be effective in treating COVID-19, the disease caused by the coronavirus.
The trials come as the Philippines is also conducting clinical trials for remdesivir, used in the treatment of Ebola, as well as interferon, an anti-viral agent, to treat COVID-19 patients.
Read more.
You may also like these stories:
Myanmar Extends COVID-19 Restrictions Until July 31
Coronavirus Treatment With Remdesivir to Cost $2,340 per Patient
